Title
Regulation of pancreatic β-cell survival by nitric oxide: Clinical relevance
Date Issued
01 March 2012
Access level
open access
Resource Type
review
Author(s)
Bedoya F.J.
Salguero-Aranda C.
Cahuana G.M.
Soria B.
Fundación Progreso Y Salud
University Pablo de Olavide
Abstract
The reduction of pancreatic β-cell mass is an important factor in the development of type 1 and type 2 diabetes. Understanding the mechanisms that regulate the maintenance of pancreatic β-cell mass as well as β-cell death is necessary for the establishment of therapeutic strategies. In this context, nitric oxide (NO) is a diatomic, gaseous, highly reactive molecule with biological activity that participates in the regulation of pancreatic β-cell mass. Two types of cellular responses can be distinguished depending on the level of NO production. First, pancreatic β-cells exposed to inflammatory cytokines, lipid stress or hyperglycaemia produce high concentrations of NO, mainly due to the activation of inducible NO synthase (iNOS), thus promoting cell death. Meanwhile, under homeostatic conditions, low concentrations of NO, constitutively produced by endothelial NO synthase (eNOS), promote cell survival. Here, we will discuss the current knowledge of the NO-dependent mechanisms activated during cellular responses, emphasizing those related to the regulation of cell survival. ©2012 Landes Bioscience.
Start page
108
End page
118
Volume
4
Issue
2
Language
English
OCDE Knowledge area
Farmacología, Farmacia Endocrinología, Metabolismo (incluyendo diabetes, hormonas)
Scopus EID
2-s2.0-84862158462
PubMed ID
Source
Islets
ISSN of the container
19382022
Sponsor(s)
apoptosis induced by high concentrations of NO through the The authors are supported by the Fundación Pública Andaluza mitochondrial-dependent pathway and the activation of signal-Progreso y Salud, Consejería de Salud, Junta de Andalucía ing pathways.150,151 Additional mechanisms of gene expression (Grant PI-0105/2010, PI-0723/2010, PI-0022/2008, CTS576 regulation by NO have been proposed as part of the protective and CTS-6505); the Ministry of Science and Innovation response.134,152 (Grant IPT-2011-1615-900000, Red TERCEL Grant Considering this background, it would be interesting to study RD06/0010/0025); Instituto de Salud Carlos III (Grant the role of low concentrations of NO in all steps of islet isolation PI10/00964, Project ANTIBECELL-CIBERDEM) and the as a promoter of survival systems, either by activating intracellu-Ministry of Health and Consumer Affairs (Advanced Therapies lar signaling pathways or by regulating the expression of survival-Program Grant TRA-120). CIBERDEM is an initiative of the related genes. This outline is based on reported evidence about Instituto de Salud Carlos III.
Sources of information: Directorio de Producción Científica Scopus